Below are the earnings highlights for Amneal Pharmaceuticals, Inc. (AMRX):
Earnings: -$91.643 million in Q1 vs. -$6.943 million in the same period last year. EPS: -$0.30 in Q1 vs. -$0.05 in the same period last year. Excluding items, Amneal Pharmaceuticals, Inc. reported adjusted earnings of $44.480 million or $0.14 per share for the period.
Analysts projected $0.09 per share Revenue: $659.191 million in Q1 vs. $557.540 million in the same period last year.
-Guidance:Full year EPS guidance: $0.53 to $0.63Full year revenue guidance: $2.55 to $2.65 Bln
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.